Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Skyrizi and Rinvoq commercial access is now at parity to Humira and above 95%. According to comments during its 2Q20 earnings call, AbbVie is making good progress in investigating expanded uses for the two relative newcomers
Continued surges in GLP-1 agonist prescriptions are expected, so clinicians that provide sedation/anaesthesia services must understand and account for the unique anaesthetic risks for these patients
Nasca and her colleagues, in collaboration with Natalie Rasgon, M.D., Ph.D., at Stanford University, have published a translational study looking at the LAC levels in two non-overlapping patient populations
In stock Contents: 10 mg lyophilized (freeze-dried) powder provided in a 3 ml vial, sealed and sterile
US$ 27.17
US$ 26.00
US$ 29.50
US$ 26.74
US$ 23.39
US$ 24.24
US$ 28.45
